Overexpression of laminin-5 gamma-2 promotes tumorigenesis of pancreatic ductal adenocarcinoma through EGFR/ERK1/2/AKT/mTOR cascade
Pancreatic ductal adenocarcinoma (PDAC) is correlated with poor outcomes because of
limited therapeutic options. Laminin-5 gamma-2 (LAMC2) plays a critical role in key …
limited therapeutic options. Laminin-5 gamma-2 (LAMC2) plays a critical role in key …
Treatment-Free Remission—A New Aim in the Treatment of Chronic Myeloid Leukemia
P Kwaśnik, K Giannopoulos - Journal of Personalized Medicine, 2021 - mdpi.com
Tyrosine kinases inhibitors (TKIs) revolutionized chronic myeloid leukemia (CML) treatment
for many years, prolonging patients' life expectancy to be comparable to age-matched …
for many years, prolonging patients' life expectancy to be comparable to age-matched …
[HTML][HTML] Emerging role of sperm-associated antigen 9 in tumorigenesis
J Pan, H Yu, Z Guo, Q Liu, M Ding, K Xu… - Biomedicine & …, 2018 - Elsevier
Abstract Sperm-associated antigen 9 (SPAG9) is a new member of cancer testis antigen and
belongs to c-Jun NH2-terminal kinase (JNK) interacting protein (JIP) family. SPAG9 is highly …
belongs to c-Jun NH2-terminal kinase (JNK) interacting protein (JIP) family. SPAG9 is highly …
A novel cancer testis antigen, A-kinase anchor protein 4 (AKAP4) is a potential biomarker for breast cancer
S Saini, N Jagadish, A Gupta, A Bhatnagar, A Suri - PLoS One, 2013 - journals.plos.org
Background Breast cancer is the second leading cause of cancer related deaths in women
worldwide. Reports about the early diagnosis of breast cancer are suggestive of an …
worldwide. Reports about the early diagnosis of breast cancer are suggestive of an …
The novel cancer-testis antigen A-kinase anchor protein 4 (AKAP4) is a potential target for immunotherapy of ovarian serous carcinoma
Ovarian cancer is one of the neoplasms affecting the reproductive tract associated with high
mortality rate because of limited therapeutic options and an elevated incidence of …
mortality rate because of limited therapeutic options and an elevated incidence of …
A new monoclonal antibody detects downregulation of protein tyrosine phosphatase receptor type γ in chronic myeloid leukemia patients
M Vezzalini, A Mafficini, L Tomasello… - Journal of hematology & …, 2017 - Springer
Background Protein tyrosine phosphatase receptor gamma (PTPRG) is a ubiquitously
expressed member of the protein tyrosine phosphatase family known to act as a tumor …
expressed member of the protein tyrosine phosphatase family known to act as a tumor …
[HTML][HTML] SPAG9 promotes prostate cancer proliferation and metastasis via MAPK signaling pathway
C Xiao, M Li, Q Huang, J Si-Tu - American journal of translational …, 2019 - ncbi.nlm.nih.gov
Prostate cancer (PCa) is a worldwide malignant tumor which seriously threats the
reproductive health of middle-aged and senior male. Sperm-associated antigen 9 (SPAG9) …
reproductive health of middle-aged and senior male. Sperm-associated antigen 9 (SPAG9) …
Antigens in chronic myeloid leukemia: implications for vaccine development
M Šmahel - Cancer Immunology, Immunotherapy, 2011 - Springer
Abstract Treatment with imatinib mesylate and other tyrosine kinase inhibitors (TKI)
revolutionized the therapy of chronic myeloid leukemia (CML). However, it alone does not …
revolutionized the therapy of chronic myeloid leukemia (CML). However, it alone does not …
[HTML][HTML] Targeting cancer testis antigens for biomarkers and immunotherapy in colorectal cancer: Current status and challenges
A Suri, N Jagadish, S Saini, N Gupta - World journal of …, 2015 - ncbi.nlm.nih.gov
Colorectal cancer ranks third among the estimated cancer cases and cancer related
mortalities in United States in 2014. Early detection and efficient therapy remains a …
mortalities in United States in 2014. Early detection and efficient therapy remains a …
A negative feedback loop between JNK-associated leucine zipper protein and TGF-β1 regulates kidney fibrosis
Q Yan, K Zhu, L Zhang, Q Fu, Z Chen, S Liu… - Communications …, 2020 - nature.com
Renal fibrosis is controlled by profibrotic and antifibrotic forces. Exploring anti-fibrosis factors
and mechanisms is an attractive strategy to prevent organ failure. Here we identified the JNK …
and mechanisms is an attractive strategy to prevent organ failure. Here we identified the JNK …